News/Media
Our Latest Updates & News
Lectenz Bio Signs Distribution Agreement with Hölzel Diagnostika
Lectenz Bio has recently signed a distribution agreement with Hölzel Diagnostika, a life sciences distributor. This agreement will allow...
Lectenz Bio Signs Distribution Agreement with 2B Scientific
Lectenz Bio has recently signed a distribution agreement with 2B Scientific, a life sciences distributor. This agreement will allow 2B...
Lectenz Bio Signs Distribution Agreement with Funakoshi
Lectenz Bio has recently signed a distribution agreement with Funakoshi Co., Ltd., a Japanese life science distributor. This agreement...
COVID-19 Update from Lectenz Bio
We’d like to take a brief moment to update you on our company plans as the COVID-19 situation progresses. At Lectenz Bio, our employees’...
Lectenz Bio awarded NIH NIGMS SBIR Phase I
The NIH National Institute of General Medical Sciences (NIGMS) awards Lectenz Bio an SBIR Phase I to develop heparan...
Lectenz Bio receives NIH NIGMS SBIR Phase I
The NIH National Institute of General Medical Sciences (NIGMS) awards Lectenz Bio an SBIR Phase I to develop...
Lectenz Bio at ACS Fall 2019 National Meeting
Lectenz Bio attended the ACS Fall 2019 National Meeting, where Dr. Matthew Saunders presented Glycosense™: Simple alternative to...
ASBMB Featured Story Highlights Lectenz Bio Founders
Lectenz Bio founders, Lori Yang and Rob Woods are highlighted in an ASBMB featured story, Setting Sail in a Startup: How academic...
Lectenz Bio sponsors EUROCARB XX
Christian Gerner-Smidt and Lori Yang attended the 20th European Carbohydrate Symposium in Leiden, The Netherlands. Dr. Yang gave a lecture...
Browse our products